Evidence map›Paper›PMID 39748040›Full record

ArticleScientific reports2025

Hybrid in-situ and ex-situ hydrolysis of catalytic epoxidation neem oil via a peracid mechanism.

Ismail Md Rasib, Mohd Jumain Jalil, Nabisab Mujawar Mubarak, Intan Suhada Azmi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ismail Md RasibChemical Engineering Studies, College of Engineering, Universiti Teknologi MARA, Cawangan Johor, Kampus Pasir Gudang, Masai Johor, 81750, Malaysia.
Mohd Jumain JalilChemical Engineering Studies, College of Engineering, Universiti Teknologi MARA, Cawangan Johor, Kampus Pasir Gudang, Masai Johor, 81750, Malaysia. jumain.jalil@gmail.com.
Nabisab Mujawar MubarakChemical and Energy Engineering, Faculty of Engineering, Universiti Teknologi Brunei, Bandar Seri Begawan, BE1410, Brunei Darussalam. mubarak.yaseen@gmail.com.
Intan Suhada AzmiChemical Engineering Studies, College of Engineering, Universiti Teknologi MARA, Cawangan Johor, Kampus Pasir Gudang, Masai Johor, 81750, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The depletion of oil reserves and their price and availability volatility raise researchers' concerns about renewable resources for epoxidized material. This study aims to produce in situ and ex-situ hydrolyzed dihydroxy stearic acid via the epoxidation of neem oil. Epoxidized neem oil was synthesized using in situ-generated performic acid. The Taguchi method was employed to optimize hydrolysis, aiming for maximum production of dihydroxystearic acid. The Taguchi method's signal-to-noise (S/N) ratio analysis identified optimal conditions for producing dihydroxy stearic acid with a maximum hydroxyl value of 129.4 mg KOH/g: (1) water/neem oil molar ratio of 2:1, (2) water addition time of 90 min, and (3) reaction stop time of 120 min. ANOVA revealed the significant order of parameters as reaction stop time > water addition time > water/neem oil molar ratio. Lastly, a mathematical model was developed using MATLAB, applying the fourth-order Runge-Kutta method and simulated annealing optimization to determine the best-fitting kinetic model. This research aids in transforming neem oil into a value-added product, reduces petroleum dependence, and provides key insights into reaction kinetics for industrial applications.

Indexed as

Biomass conversionDihydroxy stearic acidNeem oilTaguchi

Identifiers

PMID39748040
PMCPMC11695830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.